Month: February 2026
Cooley’s 2026 Year Ahead for Life Sciences M&A: Competition and Creativity in a Dynamic Environment
This time last year, we wistfully remarked that M&A activity in the life sciences sector had decided to slim down and join the GLP-1 trend. Since then, dealmakers in the space have discovered their appetite again – and then some. Johnson & Johnson (J&J) kicked off 2025 with its $14.6 […]
Cooley’s 2025 Tech M&A Year in Review: Tech M&A Revival – Big Deals Keep on Turnin’
Despite early macro-headwinds, tech dealmakers were active in 2025, anchored by strategic acquirers making decisive moves to improve their positioning in a rapidly changing market environment and private equity sponsors undertaking audacious mega-cap take-privates not seen since 2007. Tech M&A increased 36% and 9% year over year by deal value […]